To explore whether there is a correlation between the CD61 status and patient survival, we performed an immunohistochemical analysis on panels of a tissue microarray containing 100 archived human lung cancer samples of different stages and histological types using a CD61 antibody. Here, ITGB3 is linked to lung cancer.